Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

AstraZeneca Total Long Term Liabilities 2010-2025 | AZN

AstraZeneca total long term liabilities from 2010 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.
  • AstraZeneca total long term liabilities for the quarter ending March 31, 2025 were $35.993B, a 0.28% increase year-over-year.
  • AstraZeneca total long term liabilities for 2024 were $35.298B, a 12.37% increase from 2023.
  • AstraZeneca total long term liabilities for 2023 were $31.411B, a 5.19% decline from 2022.
  • AstraZeneca total long term liabilities for 2022 were $33.132B, a 23.8% decline from 2021.
  
AstraZeneca Annual Total Long Term Liabilities
(Millions of US $)
2024 $35,298
2023 $31,411
2022 $33,132
2021 $43,482
2020 $30,784
2019 $28,664
2018 $30,315
2017 $30,329
2016 $30,601
2015 $26,678
2014 $21,619
2013 $16,595
2012 $15,685
2011 $13,612
2010 $15,930
2009 $16,459
AstraZeneca Quarterly Total Long Term Liabilities
(Millions of US $)
2025-03-31 $35,993
2024-12-31 $35,298
2024-09-30 $38,191
2024-06-30 $36,176
2024-03-31 $35,891
2023-12-31 $31,411
2023-09-30 $30,277
2023-06-30 $32,752
2023-03-31 $36,016
2022-12-31 $33,132
2022-09-30 $34,181
2022-06-30 $38,813
2022-03-31 $41,174
2021-12-31 $43,482
2021-09-30 $43,660
2021-06-30 $35,726
2021-03-31 $28,967
2020-12-31 $30,784
2020-09-30 $31,552
2020-06-30 $28,088
2020-03-31 $27,952
2019-12-31 $28,664
2019-09-30 $30,461
2019-06-30 $30,784
2019-03-31 $30,770
2018-12-31 $30,315
2018-09-30 $32,658
2018-06-30 $29,871
2018-03-31 $30,544
2017-12-31 $30,329
2017-09-30 $34,677
2017-06-30 $34,050
2017-03-31 $30,751
2016-12-31 $30,601
2016-09-30 $32,928
2016-06-30 $34,694
2016-03-31 $31,749
2015-12-31 $26,678
2015-09-30 $20,714
2015-06-30 $20,720
2015-03-31 $20,987
2014-12-31 $21,619
2014-09-30 $19,874
2014-06-30 $20,165
2014-03-31 $20,400
2013-12-31 $16,595
2013-09-30 $15,999
2013-06-30 $15,378
2013-03-31 $15,979
2012-12-31 $15,685
2012-09-30 $16,065
2012-06-30 $14,355
2012-03-31 $13,248
2011-12-31 $13,612
2011-09-30 $13,765
2011-06-30 $15,753
2011-03-31 $15,971
2010-12-31 $15,930
2010-09-30 $17,226
2010-06-30 $16,078
2010-03-31 $16,193
2009-12-31 $16,459
2009-09-30 $17,230
2009-06-30 $17,115
2009-03-31 $16,937
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $228.688B $54.073B
AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition of rare disease drugmaker, Alexion. The acquisition added Alexion's five marketed rare disease products and its pipeline of immune-mediated rare disease candidates.In order to bolster its respiratory portfolio, AstraZeneca acquired rights to Allergan's branded respiratory business in the U.S. and Canada in Mar 2015. The company also acquired Takeda's core respiratory business in May 2016.In June 2007, AstraZeneca acquired biotechnology company MedImmune. In Aug 2011, AstraZeneca sold its Astra Tech business to DENTSPLY. AstraZeneca entered into a number of deals and struck agreements with companies such as FibroGen and Daiichi Sankyo.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $156.908B 14.06
Gilead Sciences (GILD) United States $135.961B 14.12
Vertex Pharmaceuticals (VRTX) United States $116.185B 0.00
Bristol Myers Squibb (BMY) United States $102.080B 6.83
GSK (GSK) United Kingdom $85.304B 10.20
CSL (CSLLY) Australia $75.905B 0.00
Regeneron Pharmaceuticals (REGN) United States $55.991B 13.59
Alnylam Pharmaceuticals (ALNY) United States $38.931B 0.00
Argenex SE (ARGX) Netherlands $35.107B 95.83
BioNTech SE (BNTX) Germany $25.352B 0.00
Biogen (BIIB) United States $19.497B 8.41
Royalty Pharma (RPRX) United States $19.144B 8.09
Insmed (INSM) United States $17.846B 0.00
Genmab (GNMSF) Denmark $14.821B 15.15
Genmab (GMAB) Denmark $14.511B 16.28
Illumina (ILMN) United States $13.858B 26.29
Incyte (INCY) United States $13.327B 101.25
Swedish Orphan Biovitrum (BIOVF) Sweden $11.389B 29.08
Exelixis (EXEL) United States $11.298B 19.18
BioMarin Pharmaceutical (BMRN) United States $10.962B 17.81
Moderna (MRNA) United States $10.732B 0.00
Exact Sciences (EXAS) United States $10.500B 0.00
Ascendis Pharma (ASND) Denmark $10.491B 0.00
QIAGEN (QGEN) Netherlands $10.385B 20.21
Blueprint Medicines (BPMC) United States $8.263B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $8.102B 0.00
Bio-Techne Corp (TECH) United States $8.080B 30.14
Roivant Sciences (ROIV) United Kingdom $7.668B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.666B 0.00
Revolution Medicines (RVMD) United States $7.598B 0.00
Repligen (RGEN) United States $7.416B 83.02
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Legend Biotech (LEGN) United States $6.724B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.686B 6.57
Halozyme Therapeutics (HALO) United States $6.635B 12.70
TG Therapeutics (TGTX) United States $6.083B 159.67
Guardant Health (GH) United States $6.074B 0.00
Telix Pharmaceuticals (TLX) Australia $5.761B 0.00
Nuvalent (NUVL) United States $5.523B 0.00
Axsome Therapeutics (AXSM) United States $5.321B 0.00
Zealand Pharma (ZLDPF) Denmark $5.265B 0.00
ADMA Biologics Inc (ADMA) United States $5.221B 39.05
Alkermes (ALKS) Ireland $5.145B 13.81
Vaxcyte (PCVX) United States $4.572B 0.00
Zai Lab (ZLAB) China $4.568B 0.00
Akero Therapeutics (AKRO) United States $4.221B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.125B 0.00
Krystal Biotech (KRYS) United States $4.035B 31.10
PTC Therapeutics (PTCT) United States $4.028B 7.01
Cytokinetics (CYTK) United States $3.954B 0.00
Avidity Biosciences (RNA) United States $3.858B 0.00
Merus (MRUS) Netherlands $3.810B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.732B 32.79
Sarepta Therapeutics (SRPT) United States $3.716B 0.00
Arcellx (ACLX) United States $3.646B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.586B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.546B 0.00
SpringWorks Therapeutics (SWTX) United States $3.523B 0.00
Metsera (MTSR) United States $3.473B 0.00
Protagonist Therapeutics (PTGX) United States $3.430B 73.79
Viking Therapeutics (VKTX) United States $3.251B 0.00
Kymera Therapeutics (KYMR) United States $3.151B 0.00
Scholar Rock Holding (SRRK) United States $3.134B 0.00
Alvotech (ALVO) Luxembourg $3.048B 17.43
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.990B 0.00
ImmunityBio (IBRX) United States $2.860B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.827B 0.00
Immunovant (IMVT) United States $2.760B 0.00
Ascentage Pharma Group - (AAPG) China $2.592B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.475B 0.00
Apellis Pharmaceuticals (APLS) United States $2.422B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.400B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.312B 0.00
Bavarian Nordic (BVNRY) Denmark $2.238B 11.82
Ligand Pharmaceuticals (LGND) United States $2.226B 0.00
Vericel (VCEL) United States $2.224B 1472.67
Denali Therapeutics (DNLI) United States $2.207B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.205B 0.00
Twist Bioscience (TWST) United States $2.106B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.018B 13.41
CG Oncology (CGON) United States $1.996B 0.00
Agios Pharmaceuticals (AGIO) United States $1.993B 0.00
Certara (CERT) United States $1.976B 36.91
Apogee Therapeutics (APGE) United States $1.954B 0.00
Belite Bio (BLTE) United States $1.945B 0.00
NovoCure (NVCR) Jersey $1.935B 0.00
IDEAYA Biosciences (IDYA) United States $1.920B 0.00
Amicus Therapeutics (FOLD) United States $1.891B 204.67
Beam Therapeutics (BEAM) United States $1.799B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.786B 0.00
Disc Medicine (IRON) United States $1.762B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.721B 0.00
Edgewise Therapeutics (EWTX) United States $1.657B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.637B 0.00
Adaptive Biotechnologies (ADPT) United States $1.615B 0.00
Biohaven (BHVN) United States $1.602B 0.00
BGM Group (BGM) China $1.590B 0.00
GRAIL (GRAL) United States $1.578B 0.00
Mesoblast (MESO) Australia $1.517B 0.00
Janux Therapeutics (JANX) United States $1.507B 0.00
89BIO (ETNB) United States $1.466B 0.00
Vera Therapeutics (VERA) United States $1.409B 0.00
ANI Pharmaceuticals (ANIP) United States $1.360B 14.01
Celldex Therapeutics (CLDX) United States $1.356B 0.00
Viridian Therapeutics (VRDN) United States $1.313B 0.00
Structure Therapeutics (GPCR) United States $1.303B 0.00
Travere Therapeutics (TVTX) United States $1.289B 0.00
Anbio Biotechnology (NNNN) Germany $1.248B 0.00
Dynavax Technologies (DVAX) United States $1.222B 72.71
Liquidia Technologies (LQDA) United States $1.208B 0.00
MannKind (MNKD) United States $1.179B 24.25
Novavax (NVAX) United States $1.148B 2.68
Pacira BioSciences (PCRX) United States $1.127B 10.72
Niagen Bioscience (NAGE) United States $1.108B 156.33
WAVE Life Sciences (WVE) Singapore $1.108B 0.00
Spyre Therapeutics (SYRE) United States $1.085B 0.00
Mineralys Therapeutics (MLYS) United States $1.013B 0.00
NeoGenomics (NEO) United States $1.008B 0.00
CorMedix Inc (CRMD) United States $0.990B 66.32
Geron (GERN) United States $0.981B 0.00
AbCellera Biologics (ABCL) Canada $0.964B 0.00
Nurix Therapeutics (NRIX) United States $0.963B 0.00
Arcus Biosciences (RCUS) United States $0.961B 0.00
MiMedx (MDXG) United States $0.948B 22.93
Syndax Pharmaceuticals (SNDX) United States $0.938B 0.00
CureVac (CVAC) Germany $0.913B 4.42
Praxis Precision Medicines (PRAX) United States $0.908B 0.00
Zymeworks (ZYME) United States $0.896B 0.00
Pharvaris (PHVS) Netherlands $0.892B 0.00
UniQure (QURE) Netherlands $0.888B 0.00
Intellia Therapeutics (NTLA) United States $0.867B 0.00
Oculis Holding AG (OCS) Switzerland $0.857B 0.00
LENZ Therapeutics (LENZ) United States $0.844B 0.00
Cogent Biosciences (COGT) United States $0.827B 0.00
Immunome (IMNM) United States $0.826B 0.00
ArriVent BioPharma (AVBP) United States $0.797B 0.00
Pharming Group (PHGUF) Netherlands $0.795B 0.00
Gyre Therapeutics (GYRE) United States $0.791B 211.00
Pharming Group (PHAR) Netherlands $0.787B 0.00
Sionna Therapeutics (SION) United States $0.762B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
Replimune (REPL) United States $0.754B 0.00
Nuvation Bio (NUVB) United States $0.749B 0.00
Iovance Biotherapeutics (IOVA) United States $0.748B 0.00
Trevi Therapeutics (TRVI) United States $0.733B 0.00
Vir Biotechnology (VIR) United States $0.726B 0.00
Immatics (IMTX) Germany $0.724B 0.00
GH Research (GHRS) Ireland $0.717B 0.00
Anavex Life Sciences (AVXL) United States $0.700B 0.00
AnaptysBio (ANAB) United States $0.693B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.684B 0.00
Arbutus Biopharma (ABUS) United States $0.670B 0.00
Oric Pharmaceuticals (ORIC) United States $0.668B 0.00
Bicara Therapeutics (BCAX) United States $0.648B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.631B 0.00
Upstream Bio (UPB) United States $0.628B 0.00
Stoke Therapeutics (STOK) United States $0.628B 14.56
Sana Biotechnology (SANA) United States $0.609B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.607B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.606B 0.00
Kura Oncology (KURA) United States $0.599B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.596B 0.00
Dianthus Therapeutics (DNTH) United States $0.583B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.572B 0.00
Keros Therapeutics (KROS) United States $0.560B 0.00
Arvinas (ARVN) United States $0.560B 0.00
Maze Therapeutics (MAZE) United States $0.560B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.559B 0.00
Tyra Biosciences (TYRA) United States $0.540B 0.00
Castle Biosciences (CSTL) United States $0.532B 36.16
Cullinan Therapeutics (CGEM) United States $0.530B 0.00
Opthea (OPT) Australia $0.525B 0.00
MeiraGTx Holdings (MGTX) United States $0.521B 0.00
Tango Therapeutics (TNGX) United States $0.514B 0.00
REGENXBIO (RGNX) United States $0.512B 0.00
Zenas BioPharma (ZBIO) United States $0.507B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.494B 0.00
Fortrea Holdings (FTRE) United States $0.491B 13.57
ATyr Pharma (ATYR) United States $0.480B 0.00
Myriad Genetics (MYGN) United States $0.477B 0.00
Celcuity (CELC) United States $0.473B 0.00
Abivax SA (ABVX) France $0.471B 0.00
PureTech Health (PRTC) United States $0.462B 0.00
Septerna (SEPN) United States $0.458B 0.00
Precigen (PGEN) United States $0.443B 0.00
Rapport Therapeutics (RAPP) United States $0.442B 0.00
Tectonic Therapeutic (TECX) United States $0.439B 0.00
Cytek Biosciences (CTKB) United States $0.436B 0.00
Benitec Biopharma (BNTC) United States $0.435B 0.00
Erasca (ERAS) United States $0.431B 0.00
Sage Therapeutics (SAGE) United States $0.424B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.421B 0.00
Eton Pharmaceuticals (ETON) United States $0.405B 0.00
Kamada (KMDA) Israel $0.400B 23.97
Humacyte (HUMA) United States $0.394B 0.00
Absci (ABSI) United States $0.384B 0.00
ITeos Therapeutics (ITOS) United States $0.383B 0.00
Northwest Biotherapeutics (NWBO) United States $0.381B 0.00
Rezolute (RZLT) United States $0.372B 0.00
Checkpoint Therapeutics (CKPT) United States $0.371B 0.00
Fulcrum Therapeutics (FULC) United States $0.369B 0.00
Vigil Neuroscience (VIGL) United States $0.367B 0.00
MBX Biosciences (MBX) United States $0.366B 0.00
Emergent Biosolutions (EBS) United States $0.362B 0.00
Terns Pharmaceuticals (TERN) United States $0.358B 0.00
Solid Biosciences (SLDB) United States $0.357B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.350B 0.00
Ocugen (OCGN) United States $0.339B 0.00
Inventiva S.A (IVA) France $0.339B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.337B 0.00
Urogen Pharma (URGN) United States $0.337B 0.00
Compass Therapeutics (CMPX) United States $0.336B 0.00
Aura Biosciences (AURA) United States $0.333B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.328B 0.00
Verastem (VSTM) United States $0.328B 0.00
Astria Therapeutics (ATXS) United States $0.327B 0.00
Cidara Therapeutics (CDTX) United States $0.325B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.324B 0.00
Alpha Teknova (TKNO) United States $0.319B 0.00
Abeona Therapeutics (ABEO) United States $0.318B 0.00
Allogene Therapeutics (ALLO) United States $0.317B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.311B 63.12
Corvus Pharmaceuticals (CRVS) United States $0.307B 0.00
XOMA Royalty (XOMA) United States $0.300B 0.00
Entrada Therapeutics (TRDA) United States $0.300B 9.75
Neurogene (NGNE) United States $0.298B 0.00
Gossamer Bio (GOSS) United States $0.293B 0.00
Palvella Therapeutics (PVLA) United States $0.280B 0.00
Olema Pharmaceuticals (OLMA) United States $0.279B 0.00
Annexon (ANNX) United States $0.276B 0.00
Prothena (PRTA) Ireland $0.275B 0.00
Amarin (AMRN) Ireland $0.274B 0.00
Candel Therapeutics (CADL) United States $0.274B 0.00
Atea Pharmaceuticals (AVIR) United States $0.272B 0.00
Cartesian Therapeutics (RNAC) United States $0.270B 0.00
Prima BioMed (IMMP) Australia $0.270B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.270B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Cardiff Oncology (CRDF) United States $0.257B 0.00
Inozyme Pharma (INZY) United States $0.256B 0.00
Foghorn Therapeutics (FHTX) United States $0.255B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.254B 0.00
Lifecore Biomedical (LFCR) United States $0.250B 0.00
Semper Paratus Acquisition (TVGN) United States $0.246B 0.00
Tvardi Therapeutics (TVRD) United States $0.245B 0.00
Aardvark Therapeutics (AARD) United States $0.245B 0.00
MaxCyte (MXCT) United States $0.245B 0.00
Instil Bio (TIL) United States $0.240B 0.00
DBV Technologies S.A (DBVT) France $0.239B 0.00
Third Harmonic Bio (THRD) United States $0.237B 0.00
BioStem Technologies (BSEM) $0.233B 9.50
ACELYRIN, INC (SLRN) United States $0.229B 0.00
CytomX Therapeutics (CTMX) United States $0.227B 5.88
Adherex Technologies (FENC) United States $0.226B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.223B 0.00
Design Therapeutics (DSGN) United States $0.221B 0.00
ScPharmaceuticals (SCPH) United States $0.215B 0.00
Adocia (ADOCY) France $0.213B 0.00
AC Immune (ACIU) Switzerland $0.213B 0.00
Kodiak Sciences (KOD) United States $0.213B 0.00
Inhibrx Biosciences (INBX) United States $0.213B 0.13
Monopar Therapeutics (MNPR) United States $0.212B 0.00
GENFIT S.A (GNFT) France $0.210B 0.00
CARGO Therapeutics (CRGX) United States $0.207B 0.00
I-Mab (IMAB) United States $0.203B 0.00
Prime Medicine (PRME) United States $0.201B 0.00
Codexis (CDXS) United States $0.196B 0.00
Bright Minds Biosciences (DRUG) United States $0.195B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.191B 0.00
Sagimet Biosciences (SGMT) United States $0.190B 0.00
Voyager Therapeutics (VYGR) United States $0.187B 0.00
INmune Bio (INMB) United States $0.186B 0.00
Innate Pharma S.A (IPHA) France $0.185B 0.00
Nuvectis Pharma (NVCT) United States $0.184B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.180B 0.00
Fate Therapeutics (FATE) United States $0.178B 0.00
Puma Biotechnology (PBYI) United States $0.176B 4.60
Ventyx Biosciences (VTYX) United States $0.174B 0.00
DiaMedica Therapeutics (DMAC) United States $0.173B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.171B 0.00
Actuate Therapeutics (ACTU) United States $0.170B 0.00
Editas Medicine (EDIT) United States $0.170B 0.00
EnGene Holdings (ENGN) Canada $0.164B 0.00
Alector (ALEC) United States $0.163B 0.00
Anika Therapeutics (ANIK) United States $0.162B 0.00
BioAge Labs (BIOA) United States $0.159B 0.00
Spero Therapeutics (SPRO) United States $0.157B 0.00
Alumis (ALMS) United States $0.155B 0.00
Compugen (CGEN) Israel $0.155B 0.00
Alpha Cognition (ACOG) Canada $0.154B 0.00
Galena Biopharma (SLS) United States $0.150B 0.00
23andMe Holding (MEHCQ) United States $0.149B 0.00
Neumora Therapeutics (NMRA) United States $0.149B 0.00
Molecular Partners AG (MOLN) Switzerland $0.146B 0.00
Rapt Therapeutics (RAPT) United States $0.146B 0.00
Kyverna Therapeutics (KYTX) United States $0.143B 0.00
Nkarta (NKTX) United States $0.142B 0.00
Agenus (AGEN) United States $0.141B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.141B 0.00
Black Diamond Therapeutics (BDTX) United States $0.135B 39.50
Seer (SEER) United States $0.129B 0.00
Greenwich LifeSciences (GLSI) United States $0.129B 0.00
Elicio Therapeutics (ELTX) United States $0.127B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.121B 0.00
Sangamo Therapeutics (SGMO) United States $0.121B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.121B 0.00
BioHarvest Sciences (BHST) Canada $0.120B 0.00
Contineum Therapeutics (CTNM) United States $0.118B 0.00
BeyondSpring (BYSI) United States $0.117B 0.00
Theratechnologies (THTX) Canada $0.117B 0.00
TuHURA Biosciences (HURA) United States $0.116B 0.00
EXoZymes (EXOZ) United States $0.110B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.110B 0.00
Caribou Biosciences (CRBU) United States $0.110B 0.00
C4 Therapeutics (CCCC) United States $0.108B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.106B 0.00
Invivyd (IVVD) United States $0.104B 0.00
Tenaya Therapeutics (TNYA) United States $0.103B 0.00
Citius Oncology (CTOR) United States $0.102B 0.00
Genelux (GNLX) United States $0.100B 0.00
IO Biotech (IOBT) Denmark $0.099B 0.00
HilleVax (HLVX) United States $0.098B 0.00
Entera Bio (ENTX) Israel $0.095B 0.00
Whitehawk Therapeutics (WHWK) United States $0.094B 0.00
Coya Therapeutics (COYA) United States $0.094B 0.00
Biomea Fusion (BMEA) United States $0.094B 0.00
Coherus Oncology (CHRS) United States $0.093B 0.00
Adagene (ADAG) China $0.093B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.093B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.092B 0.00
Nautilus Biotechnology (NAUT) United States $0.091B 0.00
TScan Therapeutics (TCRX) United States $0.091B 0.00
Pliant Therapeutics (PLRX) United States $0.090B 0.00
Cabaletta Bio (CABA) United States $0.089B 0.00
Zura Bio (ZURA) United States $0.086B 0.00
XBiotech (XBIT) United States $0.086B 0.00
Climb Bio (CLYM) United States $0.085B 0.00
Jasper Therapeutics (JSPR) United States $0.084B 0.00
Immunic (IMUX) United States $0.083B 0.00
Forte Biosciences (FBRX) United States $0.083B 0.00
Elutia (ELUT) United States $0.083B 0.00
PDS Biotechnology (PDSB) United States $0.080B 0.00
Cellectis S.A (CLLS) France $0.079B 0.00
OKYO Pharma (OKYO) $0.079B 0.00
Inovio Pharmaceuticals (INO) United States $0.078B 0.00
Immuneering (IMRX) United States $0.076B 0.00
IGM Biosciences (IGMS) United States $0.076B 0.00
TELA Bio (TELA) United States $0.074B 0.00
Senti Biosciences (SNTI) United States $0.073B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.072B 0.00
Seres Therapeutics (MCRB) United States $0.070B 0.00
Sutro Biopharma (STRO) United States $0.070B 0.00
Genenta Science S.p.A (GNTA) Italy $0.070B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.069B 0.00
VistaGen Therapeutics (VTGN) United States $0.068B 0.00
Immix Biopharma (IMMX) United States $0.068B 0.00
Alto Neuroscience (ANRO) United States $0.068B 0.00
Ikena Oncology (IKNA) United States $0.068B 0.00
Skye Bioscience (SKYE) United States $0.067B 0.00
MediciNova (MNOV) United States $0.067B 0.00
Akoya Biosciences (AKYA) United States $0.066B 0.00
CervoMed (CRVO) United States $0.065B 0.00
Adicet Bio (ACET) United States $0.065B 0.00
Clearside Biomedical (CLSD) United States $0.063B 0.00
Fortress Biotech (FBIO) United States $0.062B 0.00
Repare Therapeutics (RPTX) Canada $0.062B 0.00
Adlai Nortye (ANL) Cayman Islands $0.062B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Oncobiologics (OTLK) United States $0.060B 0.00
Renovaro (RENB) United States $0.059B 0.00
Opus Genetics (IRD) United States $0.059B 0.00
Exicure (XCUR) United States $0.059B 0.00
Quince Therapeutics (QNCX) United States $0.057B 0.00
Precision BioSciences (DTIL) United States $0.056B 0.00
InflaRx (IFRX) Germany $0.056B 0.00
Werewolf Therapeutics (HOWL) United States $0.055B 0.00
Annovis Bio (ANVS) United States $0.055B 0.00
Kalaris Therapeutics (KLRS) United States $0.054B 0.00
Adverum Biotechnologies (ADVM) United States $0.054B 0.00
ZIVO Bioscience (ZIVO) United States $0.053B 0.00
Kronos Bio (KRON) United States $0.053B 0.00
Atara Biotherapeutics (ATRA) United States $0.053B 0.00
VTv Therapeutics (VTVT) United States $0.053B 0.00
Applied Therapeutics (APLT) United States $0.053B 0.00
Shattuck Labs (STTK) United States $0.052B 0.00
RenovoRx (RNXT) United States $0.050B 0.00
Oncolytics Biotech (ONCY) Canada $0.050B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Aligos Therapeutics (ALGS) United States $0.048B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
Artiva Biotherapeutics (ARTV) United States $0.048B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.048B 0.00
PepGen (PEPG) United States $0.047B 0.00
Mersana Therapeutics (MRSN) United States $0.047B 0.00
Connect Biopharma Holdings (CNTB) United States $0.046B 0.00
Rein Therapeutics (RNTX) United States $0.043B 0.00
Celularity (CELU) United States $0.043B 0.00
Quantum Biopharma (QNTM) Canada $0.042B 0.00
Alterity Therapeutics - (ATHE) Australia $0.041B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.041B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.040B 0.00
Scilex Holding (SCLX) United States $0.039B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.039B 0.00
OnKure Therapeutics (OKUR) United States $0.038B 0.00
Clene (CLNN) United States $0.038B 0.00
Lantern Pharma (LTRN) United States $0.036B 0.00
Medicus Pharma (MDCX) United States $0.036B 0.00
Estrella Immunopharma (ESLA) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.035B 0.00
Radiopharm Theranostics - (RADX) Australia $0.035B 0.00
Pluri (PLUR) Israel $0.035B 0.00
AN2 Therapeutics (ANTX) United States $0.034B 0.00
Kezar Life Sciences (KZR) United States $0.034B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.034B 0.00
FibroBiologics (FBLG) United States $0.033B 0.00
CAMP4 Therapeutics (CAMP) United States $0.033B 0.00
Rani Therapeutics Holdings (RANI) United States $0.033B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Cadrenal Therapeutics (CVKD) United States $0.030B 0.00
ALX Oncology Holdings (ALXO) United States $0.029B 0.00
Curis (CRIS) United States $0.029B 0.00
Imunon (IMNN) United States $0.029B 0.00
Grace Therapeutics (GRCE) Canada $0.029B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Passage Bio (PASG) United States $0.029B 0.00
ABVC BioPharma (ABVC) United States $0.028B 0.00
KALA BIO (KALA) United States $0.028B 0.00
Vor Biopharma (VOR) $0.027B 0.00
BioAtla (BCAB) United States $0.027B 0.00
Generation Bio (GBIO) United States $0.026B 0.00
CalciMedica (CALC) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Boundless Bio (BOLD) United States $0.024B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
Ovid Therapeutics (OVID) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.022B 0.00
Gelteq (GELS) Australia $0.022B 0.00
Femasys (FEMY) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.021B 0.00
Q32 Bio (QTTB) United States $0.021B 0.00
Advanced Biomed (ADVB) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
Longeveron (LGVN) United States $0.020B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.020B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.020B 0.00
Cognition Therapeutics (CGTX) United States $0.020B 0.00
Cingulate (CING) United States $0.020B 0.00
X4 Pharmaceuticals (XFOR) United States $0.019B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
Leap Therapeutics (LPTX) United States $0.018B 0.00
HOOKIPA Pharma (HOOK) United States $0.018B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
GeoVax Labs (GOVX) United States $0.017B 0.00
Beyond Air (XAIR) United States $0.017B 0.00
NextCure (NXTC) United States $0.017B 0.00
IBio (IBIO) United States $0.016B 0.00
Abpro Holdings (ABP) United States $0.015B 0.00
UNITY Biotechnology (UBX) United States $0.015B 0.00
Rallybio (RLYB) United States $0.015B 0.00
MetaVia (MTVA) United States $0.015B 0.00
Synlogic (SYBX) United States $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Allarity Therapeutics (ALLR) United States $0.013B 0.00
Edesa Biotech (EDSA) Canada $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.013B 0.00
Athira Pharma (ATHA) United States $0.013B 0.00
Bolt Biotherapeutics (BOLT) United States $0.013B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.013B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Aytu BioPharma (AYTU) United States $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
BioXcel Therapeutics (BTAI) United States $0.011B 0.00
Intensity Therapeutics (INTS) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
Eyenovia (EYEN) United States $0.010B 0.00
Evogene (EVGN) Israel $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
Novogen (KZIA) Australia $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Sensei Biotherapeutics (SNSE) United States $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
IN8bio (INAB) United States $0.008B 0.00
Apollomics (APLM) United States $0.008B 0.00
HCW Biologics (HCWB) United States $0.008B 0.00
Portage Biotech (PRTG) $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.007B 0.00
Synaptogenix (SNPX) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Capstone Holding� (CAPS) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00